Scopeora News & Life ← Home
Health

Transforming Trauma Care: The Impact of Air Ambulance Teams

A new study reveals how air ambulance teams significantly improve survival rates for trauma patients, emphasizing the need for continued investment in HEMS.

Recent research has highlighted the challenges in drawing definitive conclusions from global studies regarding Helicopter Emergency Medical Services (HEMS) and their role in trauma survival. Variations in research methodologies, limited patient samples, and inconsistent outcome definitions have hindered effective comparisons. A significant question remains: which patient demographics gain the most from helicopter-based emergency care?

Analysis of Nearly Ten Years of Trauma Data

To address these questions, researchers analyzed the outcomes of 3,225 trauma patients who received pre-hospital treatment from a singular HEMS team operating in Kent, Surrey, and Sussex, covering the period from 2013 to 2022.

The team employed a statistical approach known as Ws analysis to estimate each patient's survival odds. This method adjusted for variations in injury severity and patient demographics while also evaluating factors related to mortality within 30 days.

Survival Rates and Cardiac Arrest Insights

In their study, researchers also investigated instances where patients defied survival expectations, especially in cases of traumatic cardiac arrest, which occurs when the heart ceases to function following severe injuries like major hemorrhaging or chest trauma. A critical aspect was whether spontaneous circulation was restored before hospital arrival.

Among the patients analyzed, 2,125 survived for a minimum of 30 days post-injury, resulting in an actual survival rate of 85%, surpassing the anticipated rate of 81%. This five-percentage-point difference translates to approximately 115 additional lives saved annually based on the service's average caseload.

Identifying Beneficial Patient Groups

Patients with severe injuries and a moderate predicted survival chance (25-45%) exhibited some of the most significant improvements, with 35% surviving for 30 days despite lower expectations. Furthermore, among those with a less than 50% predicted chance of survival, 39% managed to live for at least 30 days, showcasing the effectiveness of HEMS.

Key Factors Linked to Improved Survival

Factors such as younger age and a higher initial Glasgow Coma Scale score were identified as strong indicators of unexpected survival. The Glasgow Coma Scale, ranging from 3 to 15, is utilized to assess a patient's consciousness following a brain injury.

Another critical factor was the administration of pre-hospital emergency anesthesia, which induces a coma and can only be provided by specialized medical teams like HEMS. This intervention was independently associated with enhanced survival rates among severely injured patients.

Traumatic Cardiac Arrest Outcomes

Of the 1,316 patients who suffered traumatic cardiac arrest, 356 (27%) regained circulation during transport to the hospital, while the remaining 960 were pronounced dead at the scene. For the 356 patients who initially survived, 30-day outcome data were available for 185 (52%). Among these, 46 (25%) were still alive after 30 days, while 139 succumbed after reaching the hospital. Notably, the likelihood of regaining circulation increased by 6% each year from 2013 to 2022.

Limitations and Cautious Interpretation

The researchers caution that while their findings indicate survival rates exceeding statistical predictions, this does not serve as direct evidence that HEMS is solely responsible for these improved outcomes. The estimates assume that patient characteristics and service efficacy remained stable over time, which may not always hold true.

Nevertheless, the team underscores the significant clinical benefits indicated by their findings, aligning with previous economic and social advantages documented in earlier studies. They conclude that these results advocate for ongoing investment in HEMS, especially for patients with severe injuries, though further comparative studies with alternative care models are necessary to establish definitive causal effectiveness.